Democritus University of Thrace (DUTH)
Έλεγχος της επίδρασης της βιταμίνης Ε στον τίτλο των αντιφωσφολιπιδικών αντισωμάτων και στη συχνότητα θρομβωτικών επεισοδίων σε ασθενείς που βρίσκονται σε υποκατάσταση της νεφρικής λειτουργίας με εξωνεφρική κάθαρση
Abstract
dc:descriptionThe aim of the present study was to evaluate the effects of one year alpha-tocopherol oral administration on the antioxidant status, on anticardiolipin antibodies title and, finally, on the incidence of thrombosis in hemodialysis patients. Twenty-seven patients (mean age 59 years) with chronic renal failure, under chronic hemodialysis (mean duration in hemodialysis 46 months) were included into the study. Alpha-tocopherol at a dose of 500 mg daily was administered for a period of one year. Twenty patients undergoing hemodialysis (mean age 60 years, mean duration in hemodialysis 52 months) were receiving placebo during the same period of time. Patients with autoimmune disease, cancer or history of central or peripheral vascular disease were excluded, as well as, those who were receiving antiinflammatory or immunosupressive drugs. Twenty-two healthy volunteers (mean age 56 years) were the control group. Plasma total antioxidant status (TAS) and the activities of red cell`s antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx) were assessed before and after a-tocopherol administration. Concurrently, serum IgG and IgM anticardiolipin antibodies (ACA-IgG and ACA-IgM) and the activities of the anticlotting proteins C and S were assessed. Thrombotic events were recorded for one year before, as well as, during the year of a-tocopherol administration. Results: 1. Plasma TAS was higher in hemodialysis patients compared with healthy volunteers. This is possibly due to the increased uric acid concentration in the patients with chronic renal failure plasma. No significant difference in SOD and GPx activities between hemodialysis patients and control group was found. Alpha-tocopherol administration decreased TAS and SOD activity. 2. There was statistically significant difference in ACA-IgG levels between hemodialysis patients and healthy volunteers. ACA-IgG levels were higher in hemodialysis patients compared with control group and were increased further after a-tocopherol administration. Alpha-tocopherol administration increased ACA-IgM levels too. ACA-IgG and ACA-IgM levels in patients who received placebo remained stable. 3. A statistically significant positive correlation was found between the decrease in TAS and the increase in ACA-IgG levels after a-tocopherol administration. 4. Protein C activity was decreased in hemodialysis patients compared with healthy volunteers. A-tocopherol administration did not influence protein C and S activities. 5. There was no significant difference in thrombotic events incidence before and after a-tocopherol administration. Additionally, there was no correlation between the ACA levels and the number of thrombotic events. Conclusions: 1. A-tocopherol can act, under special conditions, not as an antioxidant, but as a prooxidant. Excessive a-tocopherol intake, in combination with deficiency of other antioxidants, such as ascorbate, could result in conversion of the a-tocopherol from an antioxidant to a prooxidant. This is supported by the decreased TAS and SOD, as well as, by the increased ACA-IgG and ACA-IgM levels, that were induced by a-tocopherol administration in our study. 2. a-tocopherol administration increases ACA-IgG and ACA-IgM levels. ACA formation is probably the result of cardiolipin oxidation or cell death and cardiolipin release to the extracellular space. Oxidative stress can induce both of them. 3. Decreased anticlotting protein C activity in hemodialysis patients may contribute to the high incidence of thrombosis in these patients.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Antoniadi, Georgia
- Αντωνιάδη, Γεωργία
Subjects
dc:subject × 18- Αιμοκάθαρση
- Ελεύθερες ρίζες οξυγόνου
- Βιταμίνη Ε
- Αντιφωσφολιπιδικά αντισώματα
- Πρωτεΐνη C - (PRC)
- Πρωτεΐνη S - (PRS)
- Θρομβώσεις
- Hemodialysis
- Oxygen free radicals
- Vitamin E
- Antiphospholipid antibodies
- Protein C
- Protein S (PRS)
- Thrombosis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21139